Vaccine to prevent Dengue fever

Project 138

Problem to be solved

• Disease of worldwide range
• Severe clinical forms of the disease
• Absence of available vaccine to prevent the disease
• Difficulties in developing the tetravalent vaccine

Proposed innovation

• Tretravalent vaccine against dengue fever
• Innovative and efficient vaccinal strategy

Differential

• Protection against the four serotype of dengue fever virus
• 100% protection in murines
• High titles of neutralizing antibodies

Stage of development
Prototype

Intellectual property status
BRPI0904020-0 (corresponding PCT filed)

What we want
Partnership

Coordinator
Ada Maria de Barcelos Alves / IOC

Contact
Gestec/VPPIS – phone: 21 3882 9099/ 3882 9120 or portfolio@fiocruz.br